BA.2.86 Variant: 5 Early Signs And Symptoms Of New Covid-19 Viral Strains Pirola To Watch Out For

Canada has now identified cases of the highly mutated COVID-19 variant BA.2.86, which was previously detected in Switzerland and South Africa. This variant is reportedly contributing to an increase in COVID-19 cases in several countries, including the UAE, USA, UK, Israel, Denmark, and others. According to Reuters, BA.2.86 carries over 35 mutations in key parts of the virus, similar in number to the Omicron variant, which led to record infections.

A group of scientists worldwide suggests that while monitoring BA.2.86 is important, it is unlikely to cause a severe wave of illness and death, given the global immunity built up through vaccination and prior infections.

The World Health Organization (WHO) has categorized BA.2.86 as a 'variant under monitoring' due to its numerous mutations, though only a limited number of cases have been reported in a few countries.

What is BA.2.86?

BA.2.86, sometimes referred to as "Pirola," was initially identified in late July. It appears to have evolved from the Omicron BA.2 sublineage, which caused surges in early 2022. Notably, BA.2.86 exhibits a substantial number of mutations compared to earlier Omicron variants, making it distinct from the prevailing Omicron XBB subvariants.

BA.2.86 variant symptoms:

Currently, there is insufficient data to determine the specific symptoms associated with BA.2.86 infection. The CDC reports no evidence that this variant causes more severe illness, but this may change with further research.

Common symptoms of other COVID-19 variants include cough, sore throat, runny nose, fatigue, headache, muscle aches, and altered sense of smell. Existing tests and medications for COVID-19 appear effective against BA.2.86 based on current knowledge.

Spread of BA.2.86:

As of August 28, BA.2.86 has been linked to cases in Denmark, South Africa, the United States, Israel, and the United Kingdom. It is likely spreading more extensively than reported due to limited testing and sequencing. In the U.S., the EG.5 or Eris subvariant accounts for the largest proportion of COVID-19 infections.

Is BA.2.86 more transmissible?

It is too early to determine whether BA.2.86 is more transmissible. However, genetic analysis suggests it may have the ability to evade existing immunity, both from prior infection and vaccination. This makes it concerning from a scientific perspective, particularly regarding the efficacy of future vaccines.

Will BA.2.86 cause a surge in Covid-19 cases?

The impact of BA.2.86 on the number of COVID-19 cases remains uncertain. It is difficult to predict how much disease the variant will cause and how easily it will spread. Recent increases in cases and hospitalizations in the U.S. have been attributed to various Omicron variants, but the overall numbers remain lower than in previous surges. The death rate due to COVID-19 is decreasing.